Make Every Step Count: Personalised Music Feedback to Walking for People Living With COPD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Leicester

About this trial

Pulmonary Rehabilitation (PR) is an evidence-based intervention to effectively manage the physiological and psychological effects of Chronic Obstructive Pulmonary Disease (COPD). The aims of PR are to improve symptoms of COPD, increase exercise capacity, increase independency, improve overall behaviour related to health (like exercising more), and enhance quality of life. The cornerstone of PR programmes is aerobic exercise prescription. Typically, walking exercise is used, and the prescription is individualised for each patient based on their maximal walking exercise capacity. However, adherence to walking exercise is challenging for service users, particularly when unsupervised at home. The use of music during exercise shows promise as a tool to decrease the perception of fatigue and increase motivation, but the integration of music via smartphone applications to support walking exercise adherence during PR has not been explored. This project aims to assess if a new mobile application BeatClearWalker (BCW) intervention is practical, acceptable, and effectively used by people living with COPD. The app is designed to help people living with COPD attending PR adhere to their prescribed walking pace during exercise. The BCW app provides real-time, personalised music feedback through music degradation to optimise the dose of walking exercise.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Willing and able to provide informed consent for participation in the study.

The patient is referred for PR at the UHL.

The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria)

Male or female, aged 18+ years.

Disqualifiers

Unable to provide valid informed consent.

Lack of motivation to participate in PR programme.

Any-contra-indications absolute or relative to exercise training.

Has had a cardiac event within last 6 weeks

Trial design

Design model

Single group

Treatments tested in this trial

  • Music walking application BeatClearWalker (BCW)

    Device

    The music walking application (BCW) is a smartphone application that can monitor the walking pace and allow individuals to listen to music and give immediate feedback so they can correct their walking pace to match their target walking speed, as prescribed by the healthcare professional. The application provides real-time audio feedback in the form of music; the music sound quality will reduce whenever the walking speed drops below or exceeds the participant\'s target walking speed. Simply, the application will work to supervise service users while exercising walking. The investigators are trying to assess the feasibility of this application with service users during their Pulmonary Rehabilitation programme (at the hospital/ home) to find out how participants interact with listening to music while exercise walking and how well they're able to keep to their target speed.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Music Walking Application BeatClearWalker (BCW)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The proportion of recruited participants who do not use the BCW app.

Time frame
Post PR 6-8 weeks.
2

The proportion of recruited participants who complete the follow-up assessment.

Time frame
Upon the completion of the PR programme at 6-8 weeks.
3

The proportion of patients who meet the eligibility criteria.

The percentage of eligible from those who were screened against the eligibility criteria

Time frame
11 months
4

The proportion of individuals with COPD who express interest in participating in the study.

Time frame
11 months

Secondary outcomes

1

Medical Research Council (MRC) Dyspnoea Scale

Medical Research Council (MRC) Dyspnoea Scale , measuring the level of breathlessness. Scale: Minimum value: 1 Maximum value: 5. The higher the score, the worse the outcome (breathlessness).

Time frame
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
2

Generic Health Status Questionnaire (EQ-5D-5L)

The EQ-5D-5L evaluates generic health status, with five dimensions of health assessed. Scale: The descriptive system results in a single score; higher scores generally indicate worse outcomes.

Time frame
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
3

Generalized Anxiety Disorder 2-item (GAD-2)

The Generalized Anxiety Disorder-2 (GAD-2) is a brief screening tool for generalized anxiety disorder, measuring the frequency of anxiety symptoms over the past two weeks. Scale: Minimum score is 0, and Maximum score is 6. Higher scores indicate worse anxiety symptoms. A score of 3 points is the preferred cut-off for identifying possible cases and in which further diagnostic evaluation for generalized anxiety disorder is warranted.

Time frame
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).
4

Generalized Anxiety Disorder 7-item (GAD-7)

The Generalized Anxiety Disorder-7 (GAD-7) is a 7-item scale that measures the severity of generalized anxiety disorder symptoms over the past two weeks. Scale: The following cut-offs correlate with level of anxiety severity: Score 0-4: Minimal Anxiety Score 5-9: Mild Anxiety Score 10-14: Moderate Anxiety Score greater than 15: Severe Anxiety

Time frame
Baseline (Pre-PR) and Follow-up (Post-PR, at 6-8 weeks).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Leicester

Lead sponsor

University of Strathclyde

Collaborator

University Hospitals, Leicester

Collaborator